DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 205208
The generic ingredient in DESVENLAFAXINE is desvenlafaxine succinate. There are sixteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the desvenlafaxine succinate profile page.
Summary for 205208
Tradename: | DESVENLAFAXINE |
Applicant: | Teva Pharms Usa |
Ingredient: | desvenlafaxine fumarate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 50MG BASE | ||||
Approval Date: | Oct 11, 2013 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 100MG BASE | ||||
Approval Date: | Oct 11, 2013 | TE: | RLD: | No |
Complete Access Available with Subscription